Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by fdfd12 on Jun 09, 2016 5:22pm

Takeda

They can't give us Takeda shares.
It doesn't trade on Toront.
If we end up with Takeda, how do we sell it?
Comment by watchmeplz on Jun 09, 2016 5:26pm
Oh ya they can, they can give you a pile of poo if the shareholders accept it lol. It it would be up to your brokerage how they deal with your shares.
Comment by adamchess on Jun 09, 2016 5:51pm
I agree but I don't know if CXR management would want to operate under a japanese company. They are hard to work with I think, to put it mildly.
Comment by curiousbuild on Jun 09, 2016 5:33pm
https://www.takedacanada.com/our-products/ I am sure we can sell in US.. technology is advanced enough to figure out little details. No gong show volatility like US pharmas on Takeda chart CB
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities